Clinical Trials Logo

Clinical Trial Summary

Technical advances in lenses are continuous and materials are improved. We provide a prospective longitudinal observational study evaluating the efficacy and safety of new EyeBrid Excel hybrid lenses (LCS) in the treatment of severe ametropia and for patients with corneal irregularities. This study should include 60 patients for a period of three months. The aim of this work is to assess the improvement in the best corrected visual acuity and the good tolerance of this lens.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05036954
Study type Observational
Source University Hospital, Caen
Contact Jean-Claude Quintyn, MD, PhD
Phone 00 33 2 31 06 46 30
Email [email protected]
Status Not yet recruiting
Phase
Start date September 30, 2021
Completion date July 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04163328 - Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort Phase 4
Completed NCT03848221 - Direct Application of Systane Complete to Contact Lenses Phase 4
Completed NCT04806763 - Myopia Control With Orthokeratology Contact Lenses in Spain N/A
Not yet recruiting NCT04663529 - Correlation Study of Corneal Nerve Changes and Dry Eye in Contact Lens Wearers
Withdrawn NCT03408015 - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Phase 4
Completed NCT03305484 - Soft Contacts Observation of Risk and Education (SCORE)
Completed NCT03566680 - Treating Contact Lens Discomfort With Orthokeratology N/A
Recruiting NCT02298400 - A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses Phase 4
Completed NCT03525704 - Evaluation of Contact Lens Saline Solutions With Scleral GP Contact Lens Wearers Experiencing Fogging N/A